Profile
Sector:
HealthcareCountry:
United StatesIPO:
01 February 2013Website:
http://www.zoetis.comNext earnings report:
04 November 2024Last dividends:
18 July 2024Next dividends:
31 October 2024Price
regular market | 6 min agoAnalysts recommendations
Institutional Ownership
ZTS Latest News
ZTS' increased sales of companion animal products probably boosted revenues in the third quarter of 2024 for both the U.S. and international markets.
Zoetis (ZTS) has the right mix of factors that could lead to a strong earnings report soon. Be ready for the important expectations.
LOS ANGELES, CA / ACCESSWIRE / October 26, 2024 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
Zoetis (ZTS) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.
LOS ANGELES, CA / ACCESSWIRE / October 20, 2024 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.
LOS ANGELES, CA / ACCESSWIRE / October 19, 2024 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) has announced a dividend of $0.432 per share for the fourth quarter of 2024. This payment will be made on Tuesday, December 3, 2024, to all shareholders who own the company's common stock as of the end of business on Thursday, October 31, 2024. Zoetis is the leading company in animal health, focused on improving care for animals and supporting human well-being.
Zoetis is known for its innovative approach, developing new categories and improving care standards, which helps it outperform its rivals. The company shows careful management of its finances by making strategic investments and selling off less profitable areas, leading to ongoing growth. With its strong market position, growth potential, and attractive dividends, ZTS is a good choice for young investors looking for dividend growth.
LOS ANGELES, CA / ACCESSWIRE / October 8, 2024 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Zoetis Inc. ("Zoetis" or "the Company") (NYSE:ZTS) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
What type of business is Zoetis?
Zoetis Inc. is an American pharmaceutical company headquartered in Parsippany, New Jersey, specializing in the development, production, and sale of veterinary medicines, vaccines, and diagnostic products for the livestock and pets industry. It was founded in 2012 as a spin-off from the largest drug manufacturer, Pfizer Inc. The company is one of the largest in its industry. Its main competitive advantages include: an extensive network of technical and veterinary operations specialists, high-quality production and reliable supply, years of experience, strong customer relationships, ongoing research and development (R&D), and more.
What sector is Zoetis in?
Zoetis is in the Healthcare sector
What industry is Zoetis in?
Zoetis is in the Drug Manufacturers - Specialty & Generic industry
What country is Zoetis from?
Zoetis is headquartered in United States
When did Zoetis go public?
Zoetis initial public offering (IPO) was on 01 February 2013
What is Zoetis website?
https://www.zoetis.com
Is Zoetis in the S&P 500?
Yes, Zoetis is included in the S&P 500 index
Is Zoetis in the NASDAQ 100?
No, Zoetis is not included in the NASDAQ 100 index
Is Zoetis in the Dow Jones?
No, Zoetis is not included in the Dow Jones index
When was Zoetis the previous earnings report?
No data
When does Zoetis earnings report?
The next expected earnings date for Zoetis is 04 November 2024